The Centre for Cancer Biology (CCB) is a Medical Research Institute which carries out a world-class program of innovative research, making breakthrough discoveries in the causes of cancer, and translating these discoveries into new ways to prevent and treat this group of diseases. 

The CCB is an alliance between SA Pathology and the University of South Australia and boasts over 200 cancer researchers; currently hosting 22 full-time research group leaders and their teams.

CCB laboratories carry out research on the major cancers such as leukaemia, bowel cancer, breast cancer, prostate cancer, lung cancer, ovarian cancer and skin cancers led by distinguished full-time group leaders. A particular focus is childhood cancers and cancers that occur in the same family. In addition to these laboratories, the CCB’s ACRF Cancer Genomics Facility provides access to state-of-the-art genomics to bring precision medicine to South Australian cancer patients.

The translation of new discoveries into clinical practice is strengthened by the location of the laboratories within a single centre, as well as its proximity to the Royal Adelaide Hospital along with its clinical resources, the University of South Australia and the University of Adelaide, with which it shares key research facilities.

The CCB has alliances with other prominent national and international Institutes and leading pharmaceutical companies which have allowed many of the discoveries made in this Institute, by South Australians, to be in advanced clinical trials worldwide. In this way the CCB is becoming a hub of internationally recognised cancer research excellence, achieving tangible outcomes for cancer patients.

The CCB is a member of the Association of Australian Medical Research Institutes (AAMRI).

Professor Stuart Pitson, one of the many passionate researchers at the Centre for Cancer Biology
Professor Stuart Pitson, one of the many passionate researchers at the Centre for Cancer Biology

support the centre for cancer biology

learn more about how you are making an impact

A New Piece in the Prostate Cancer Puzzle

Scientists working tirelessly in the lab of the Centre for Cancer Biology have identified that high levels of a protein (called quaking) plays a key role in the bad prognosis of prostate cancer tumours that have become resistant to chemotherapy and other treatments. read more

National Grant Success Thanks to THRF Community

Thanks to our generous community, The Hospital Research Foundation (THRF) supports lifesaving research that will see new and improved treatments for common diseases reach our community sooner. Just recently THRF directed $75,000 in funding to Dr Natasha Harvey and her world-class team at the Centre for Cancer Biology (CCB) to support their vital work into halting the spread of common cancers and the condition of lymphoedema. read more

The Fight to Beat Triple Negative Breast Cancer

Head of the Cell Signalling Laboratory at the Centre for Cancer Biology (CCB), Associate Professor Yeesim Khew-Goodall is leading a crucial research project focused on overcoming resistance to cancer therapy, particularly in triple negative breast cancer. read more